GABA tea prevents cardiac fibrosis by attenuating TNF-alpha and Fas/FasL-mediated apoptosis in streptozotocin-induced diabetic rats

Food and Chemical Toxicology

Volumn 65, Issue , 2014, Pages 90-96

  Cherng, Shur Hueih ^a   Huang, Chih Yang ^b,c   Kuo, Wei Wen ^b   Lai, Shue Er ^a,d   Tseng, Chien Yu ^a   Lin, Yueh Min ^e,f   Tsai, Fuu Jen ^b   Wang, Hsueh Fang ^a  

^a HUNGKUANG UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d CHENG CHING GENERAL HOSPITAL   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^f JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Diabetes; Fas; GABA tea; Heart; TNF alpha

Indexed keywords

4 AMINOBUTYRIC ACID; CARDIAC AGENT; CASPASE 3; CASPASE 8; FAS ANTIGEN; FAS LIGAND; GAMMA AMINOBUTYRIC ACID TEA EXTRACT; GLUCOSE; POLYPHENOL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; HEART MUSCLE FIBROSIS; HEART PROTECTION; MALE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WESTERN BLOTTING;

DIABETES; FAS; GABA TEA; HEART; TNF-ALPHA;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; DIABETES MELLITUS, EXPERIMENTAL; FAS LIGAND PROTEIN; FIBROSIS; GAMMA-AMINOBUTYRIC ACID; HEART DISEASES; MALE; RATS; RATS, WISTAR; STREPTOZOCIN; TEA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892457128     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.12.022     Document Type: Article

References (49)

1. Abe Y., Umemura S., Sugimoto K., Hirawa N., Kato Y., Yokoyama N., Yokoyama T., Iwai J., Ishii M. Effect of green tea rich in γ-aminobutyric acid on blood pressure of Dahl saltsensitive rats. Am. J. Hypertens. 1995, 8:74-79.
2. Aikawa R., Nitta-Komatsubara Y., Kudoh S., Takano H., Nagai T., Yazaki Y., Nagai R., Komuro I. Reactive oxygen species induce cardiomyocyte apoptosis partly through TNF-alpha. Cytokine 2002, 18:179-183.
3. Babu P.V., Sabitha K.E., Shyamaladevi C.S. Effect of green tea extract on advanced glycation and cross-linking of tail tendon collagen in streptozotocin induced diabetic rats. Food Chem. Toxicol. 2008, 46:280-285.
4. Bellenger J., Bellenger S., Bataille A., Massey K.A., Nicolaou A., Rialland M., Tessier C., Kang J.X., Narce M. High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice. inflammatory pathway inhibition. Diabetes 2011, 60:1090-1099.
5. Bojunga J., Nowak D., Mitrou P.S., Hoelzer D., Zeuzem S., Chow K.U. Antioxidative treatment prevents activation of death-receptor- and mitochondrion-dependent apoptosis in the hearts of diabetic rats. Diabetologia 2004, 47:2072-2080.
6. Cabrera C., Artacho R., Gimenez R. Beneficial effects of green tea - a review. J. Am. Coll. Nutr. 2006, 25:79-99.
7. Cai L., Li W., Wang G., Guo L., Jiang Y., Kang Y.J. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 2002, 51:1938-1948.
8. Chuang S.M., Wang H.F., Hsiao C.C., Cherng S.H. Zinc ion enhances GABA tea-mediated oxidative DNA damage. J. Agric. Food Chem. 2012, 60:1586-1594.
9. Crespy V., Williamson G. A review on the health effects of green tea catechins: in vivo animal models. J. Nutr. 2004, 134:3431S-3440S.
10. de Mejia E.G., Ramirez-Mares M.V., Puangpraphant S. Bioactive components of tea: cancer, inflammation and behavior. Brain Behav. Immun. 2009, 23:721-731.
11. Deka A., Vita J.A. Tea and cardiovascular disease. Pharmacol. Res. 2011, 64:136-145.
12. Deng Y., Xu L., Zeng X., Li Z., Qin B., He N. New perspective of GABA as an inhibitor of formation of advanced lipoxidation end-products: it's interaction with malondiadehyde. J. Biomed. Nanotechnol. 2010, 6:318-324.
13. Dong H., Kumar M., Zhang Y., Gyulkhandanyan A., Xiang Y.Y., Ye B., Perrella J., Hyder A., Zhang N., Wheeler M., Lu W.Y., Wang Q. Gamma-aminobutyric acid up- and downregulates insulin secretion from beta cells in concert with changes in glucose concentration. Diabetologia 2006, 49:697-705.
14. Gosslau A., Li S., Ho C.T., Chen K.Y., Rawson N.E. The importance of natural product characterization in studies of their anti-inflammatory activity. Mol. Nutr. Food Res. 2011, 55:74-82.
15. Horie H., Kohata K. Analysis of tea components by high-performance liquid chromatography and high-performance capillary electrophoresis. J. Chromatogr. A 2000, 881:425-438.
16. Jain S.K., Kannan K., Lim G., McVie R., Bocchini J.A. Hyperketonemia increases tumor necrosis factor-α secretion in cultured U937 monocytes and type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency. Diabetes 2002, 51:2287-2293.
17. Kageyama S., Yokoo H., Tomita K., Kageyama-Yahara N., Uchimido R., Matsuda N., Yamamoto S., Hattori Y. High glucose-induced apoptosis in human coronary artery endothelial cells involves up-regulation of death receptors. Cardiovasc. Diabetol. 2011, 10:73.
18. Kao Y.H., Chang H.H., Lee M.J., Chen C.L. Tea, obesity, and diabetes. Mol. Nutr. Food Res. 2006, 50:188-210.
19. Lee S.D., Kuo W.W., Ho Y.J., Lin A.C., Tsai C.H., Wang H.F., Kuo C.H., Yang A.L., Huang C.Y., Hwang J.M. Cardiac Fas-dependent and mitochondria-dependent apoptosis in ovariectomized rats. Maturitas 2008, 61:268-277.
20. Liu R.H. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J. Nutr. 2004, 134:3479S-3485S.
21. Maedler K., Spinas G.A., Lehmann R., Sergeev P., Weber M., Fontana A., Kaiser N., Donath M.Y. Glucose induces β-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 2001, 50:1683-1690.
22. Mellado-Gil J.M., Aguilar-Diosdado M. High glucose potentiates cytokine- and streptozotocin-induced apoptosis of rat islet cells: effect on apoptosis-related genes. J. Endocrinol. 2004, 183:155-162.
23. Min W., Bin Z.W., Quan Z.B., Hui Z.J., Sheng F.G. The signal transduction pathway of PKC/NF-κB/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats. Cardiovasc. Diabetol. 2009, 8:8.
24. Moon H.S., Lee H.G., Choi Y.J., Kim T.G., Cho C.S. Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity. Chem. Biol. Interact. 2007, 167:85-98.
25. Morgan M.J., Liu Z.G. Reactive oxygen species in TNFalpha-induced signaling and cell death. Mol. Cells 2010, 30:1-12.
26. Narula J., Pandey P., Arbustini E., Haider N., Narula N., Kolodgie F.D., Dal Bello B., Semigran M.J., Bielsa-Masdeu A., Dec G.W., Israels S., Ballester M., Virmani R., Saxena S., Kharbanda S. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc. Natl. Acad. Sci. USA 1999, 96:8144-8149.
27. Poornima I.G., Parikh P., Shannon R.P. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ. Res. 2006, 98:596-605.
28. Potenza M.A., Nacci C., Gagliardi S., Montaqnani M. Cardiovascular complications in diabetes: lessons from animal models. Curr. Med. Chem. 2011, 18:1806-1819.
29. Quan Y., Jiang C.T., Xue B., Zhu S.G., Wang X. High glucose stimulates TNF α and MCP-1 expression in rat microglia via ROS and NF-κB pathways. Acta Pharmacol. Sin. 2011, 32:188-193.
30. Quine S.D., Raghu P.S. Effects of (-)-epicatechin, a flavonoid on lipid peroxidation and antioxidants in streptozotocin-induced diabetic liver, kidney and heart. Pharmacol. Rep. 2005, 57:610-615.
31. Rahman I., Biswas S.K., Kirkham P.A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol. 2006, 72:1439-1452.
32. Ramadan G., El-Beih N.M., Abd El-Ghffar E.A. Modulatory effects of black v. green tea aqueous extract on hyperglycaemia, hyperlipidaemia and liver dysfunction in diabetic and obese rat models. Br. J. Nutr. 2009, 102:1611-1619.
33. Shimizu M., Sakai H., Shirakami Y., Yasuda Y., Kubota M., Terakura D., Baba A., Ohno T., Hara Y., Tanaka T., Moriwaki H. Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice. Cancer Prev. Res. 2011, 4:396-403.
34. Shiomi T., Tsutsui H., Ikeuchi M., Matsusaka H., Hayashidani S., Suematsu N., Wen J., Kubota T., Takeshita A. Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. J. Am. Coll. Cardiol. 2003, 42:165-172.
35. Song E.K., Hur H., Han M.K. Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice. Arch. Pharm. Res. 2003, 26:559-563.
36. Song F., Jia W., Yao Y., Hu Y., Lei L., Lin J., Sun X., Liu L. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed type 2 diabetes. Clin. Sci. 2007, 112:599-606.
37. Thielecke F., Boschmann M. The potential role of green tea catechins in the prevention of the metabolic syndrome - a review. Phytochemistry 2009, 70:11-24.
38. Tian J., Dang H.N., Yong J., Chui W.S., Dizon M.P., Yaw C.K., Kaufman D.L. Oral treatment with γ-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed mice. PLoS ONE 2011, 6:e25338.
39. Townsend P.A., Scarabelli T.M., Pasini E., Gitti G., Menegazzi M., Suzuki H., Knight R.A., Latchman D.S., Stephanou A. Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. FASEB J. 2004, 18:1621-1623.
40. Tsuneki H., Ishizuka M., Terasawa M., Wu J.B., Sasaoka T., Kimura I. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol. 2004, 4:18.
41. van Heerebeek L., Hamdani N., Handoko M.L., Falcao-Pires I., Musters R.J., Kupreishvili K., Ijsselmuiden A.J., Schalkwijk C.G., Bronzwaer J.G., Diamant M., Borbély A., van der Velden J., Stienen G.J., Laarman G.J., Niessen H.W., Paulus W.J. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008, 117:43-51.
42. Vinson J.A., Zhang J. Black and green teas equally inhibit diabetic cataracts in a streptozotocin-induced rat model of diabetes. J. Agric. Food Chem. 2005, 53:3710-3713.
43. Wang H.F., Tsai Y.S., Lin M.L., Ou A.S. Comparison of bioactive components in GABA tea and green tea produced in Taiwan. Food Chem. 2006, 96:648-653.
44. Wang H.F., Chuang S.M., Hsiao C.C., Cherng S.H. A synergistic effect of GABA tea and copper(II) on DNA breakage in human peripheral lymphocytes. Food Chem. Toxicol. 2011, 49:955-962.
45. Wei D., Li J., Shen M., Jia W., Chen N., Chen T., Su D., Tian H., Zheng S., Dai Y., Zhao A. Cellular production of n-3 PUFAs and reduction of n-6-to-n-3 ratios in the pancreatic beta-cells and islets enhance insulin secretion and confer protection against cytokine-induced cell death. Diabetes 2010, 59:471-478.
46. Westermann D., Van Linthout S., Dhayat S., Dhayat N., Schmidt A., Noutsias M., Song X.Y., Spillmann F., Riad A., Schultheiss H.P., Tschöpe C. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res. Cardiol. 2007, 102:500-507.
47. Wolfram S. Effects of green tea and EGCG on cardiovascular and metabolic health. J. Am. Coll. Nutr. 2007, 26:373S-388S.
48. Wu L.Y., Juan C.C., Ho L.T., Hsu Y.P., Hwang L.S. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. J. Agric. Food Chem. 2004, 52:643-648.
49. Yan J., Zhao Y., Suo S., Liu Y., Zhao B. Green tea catechins ameliorate adipose insulin resistance by improving oxidative stress. Free Radic. Biol. Med. 2012, 52:1648-1657.